US equities
|
MU
$912.76
▲+4.01%
TSLA
$394.50
▲+5.99%
SPCX
$148.64
▲+0.78%
NVDA
$216.34
▲+2.55%
META
$631.57
▼-1.72%
AAPL
$342.78
▼-1.42%
SNDK
$1,268.94
▲+2.50%
INTC
$91.98
▲+5.77%
MU
$912.76
▲+4.01%
TSLA
$394.50
▲+5.99%
SPCX
$148.64
▲+0.78%
NVDA
$216.34
▲+2.55%
META
$631.57
▼-1.72%
AAPL
$342.78
▼-1.42%
SNDK
$1,268.94
▲+2.50%
INTC
$91.98
▲+5.77%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Subhashish Banerjee
Recent news which mentions Subhashish Banerjee
Lupus: Treatments, Research and Bristol Myers Squibb's Dedication to Patients - A Q&A With Subhashis Banerjee
June 06, 2022
Tickers
BMY
Tags
immune/mediated diseases
Subhashish Banerjee
NYSE: BMY
From
3BL Media: Corporate Social Responsibility, Energy and Health News